Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Statistics
  • Help & Advice
University of Warwick

The Library

  • Login

Tricyclic antidepressants and the incidence of certain cancers : a study using the GPRD

Tools
- Tools
+ Tools

Walker, A. J., Card, T., Bates, T. E. and Muir, Kenneth (Kenneth R.). (2011) Tricyclic antidepressants and the incidence of certain cancers : a study using the GPRD. British Journal of Cancer, Vol.104 (No.1). pp. 193-197. ISSN 0007-0920

Full text not available from this repository.
Official URL: http://dx.doi.org/10.1038/sj.bjc.6605996

Abstract

BACKGROUND: Several studies suggest links between cancer and tricyclic antidepressant use. METHODS: A case-control study using the General Practice Research Database examined whether previous tricyclic usage was associated with reduced incidence of brain (with glioma as a sub-category), breast, colorectal, lung and prostate cancers. Conditional logistic regression adjusted for age, gender, general practice, depression, smoking, body mass index, alcohol use and non-steroidal anti-inflammatory drug use. RESULTS: A total of 31 953 cancers were identified, each matched with up to two controls. We found a statistically significant reduction in tricyclic prescriptions compared with controls in glioma (odds ratio (OR) = 0.59, 95% confidence interval (CI) = 0.42-0.81) and colorectal cancer patients (OR = 0.84, CI = 0.75-0.94). These effects were dose-dependent (P-values for trend, glioma = 0.0005, colorectal = 0.001) and time-dependant (P-values for trend glioma = 0.0005, colorectal = 0.0086). The effects were cancer-type specific, with lung, breast and prostate cancers largely unaffected by antidepressant use. CONCLUSION: The biologically plausible, specific and dose-and time-dependant inverse association that we have found suggests that tricyclics may have potential for prevention of both colorectal cancer and glioma. British Journal of Cancer (2011) 104, 193-197. doi: 10.1038/sj.bjc.6605996 www.bjcancer.com Published online 16 November 2010 (C) 2011 Cancer Research UK

Item Type: Journal Article
Subjects: R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Divisions: Faculty of Medicine > Warwick Medical School > Health Sciences
Faculty of Medicine > Warwick Medical School
Journal or Publication Title: British Journal of Cancer
Publisher: Nature Publishing Group
ISSN: 0007-0920
Date: 4 January 2011
Volume: Vol.104
Number: No.1
Page Range: pp. 193-197
Identification Number: 10.1038/sj.bjc.6605996
Status: Peer Reviewed
Publication Status: Published
Funder: MRC
URI: http://wrap.warwick.ac.uk/id/eprint/41676

Data sourced from Thomson Reuters' Web of Knowledge

Request changes to a record

Actions (login required)

View Item View Item
twitter

Email us: publications@warwick.ac.uk
Contact Details
About Us